Description:
E2805 Concomitant Medication Form Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0B593E1B-ACB3-37BB-E044-0003BA3F9857
Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0B593E1B-ACB3-37BB-E044-0003BA3F9857Keywords:
Versions (8)
- 9/19/12 9/19/12 -
- 11/26/14 11/26/14 - Martin Dugas
- 11/26/14 11/26/14 - Martin Dugas
- 11/26/14 11/26/14 - Martin Dugas
- 1/8/15 1/8/15 - Martin Dugas
- 1/9/15 1/9/15 - Martin Dugas
- 1/9/15 1/9/15 - Martin Dugas
- 7/14/17 7/14/17 - Martin Dugas
Uploaded on:
July 14, 2017
DOI:
To request one please log in.License :
Creative Commons BY-NC 3.0Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Kidney Cancer NCT00326898 Treatment - E2805 Concomitant Medication Form - 2444090v1.0
No Instruction available.
- StudyEvent: E2805 Concomitant Medication Form